Phase Ib trial of trastuzumab emtansine (TE) in combination with lapatinib (L) plus nab-paclitaxel in metastatic HER2-neu overexpressed breast cancer patients: STELA trial.
Tejal Amar Patel
No relevant relationships to disclose
Jaime Alberto Mejia
No relevant relationships to disclose
Angel Augusto Rodriguez
No relevant relationships to disclose
Jenny Chee Ning Chang
No relevant relationships to disclose